Mutational spectrum of Duchenne muscular dystrophy in Spain: Study of 284 cases
Neurologia. 2017 Jul-Aug;32(6):377-385.
doi: 10.1016/j.nrl.2015.12.009.
Epub 2016 Mar 9.
[Article in
English,
Spanish]
Authors
I Vieitez
1
, P Gallano
2
, L González-Quereda
2
, S Borrego
3
, I Marcos
3
, J M Millán
4
, T Jairo
4
, C Prior
5
, J Molano
5
, M J Trujillo-Tiebas
6
, J Gallego-Merlo
6
, M García-Barcina
7
, M Fenollar
8
, C Navarro
9
Affiliations
- 1 Grupo de Patología Neonatal y Pediátrica, Enfermedades raras, Instituto de Investigación Biomédica de Ourense-Pontevedra-Vigo (IBI), Vigo, España; Complexo Hospitalario Universitario de Vigo (CHUVI), SERGAS, Vigo, España.
- 2 Departamento de Genética, Hospital de la Santa Creu i Sant Pau, Barcelona, España; CIBERER (Centro de Investigación Biomédica en Red de Enfermedades Raras), Instituto de Salud Carlos III, Madrid, España.
- 3 Departamento de Genética, Reproducción y Medicina fetal, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Sevilla, España; CIBERER (Centro de Investigación Biomédica en Red de Enfermedades Raras), Instituto de Salud Carlos III, Madrid, España.
- 4 Unidad de Genética y Diagnóstico Prenatal, Hospital Universitario La Fe, Valencia, España; CIBERER (Centro de Investigación Biomédica en Red de Enfermedades Raras), Instituto de Salud Carlos III, Madrid, España.
- 5 Instituto de Genética Médica y Molecular (INGEMM), Hospital Universitario La Paz, Madrid, España.
- 6 Departamento de Genética, Hospital Universitario Fundación Jiménez Díaz, Madrid, España; CIBERER (Centro de Investigación Biomédica en Red de Enfermedades Raras), Instituto de Salud Carlos III, Madrid, España.
- 7 Unidad de Genética, Hospital Universitario de Basurto, Vizcaya, España.
- 8 Sección de Genética Clínica, Servicio de Análisis Clínicos, Hospital Clínico San Carlos, Madrid, España.
- 9 Complexo Hospitalario Universitario de Vigo (CHUVI), SERGAS, Vigo, España. Electronic address: cnavfer@sergas.es.
Abstract
Introduction:
Duchenne muscular dystrophy (DMD) is a severe X-linked recessive neuromuscular disease that affects one in 3500 live-born males. The total absence of dystrophin observed in DMD patients is generally caused by mutations that disrupt the reading frame of the DMD gene, and about 80% of cases harbour deletions or duplications of one or more exons.
Methods:
We reviewed 284 cases of males with a genetic diagnosis of DMD between 2007 and 2014. These patients were selected from 8 Spanish reference hospitals representing most areas of Spain. Multiplex PCR, MLPA, and sequencing were performed to identify mutations.
Results:
Most of these DMD patients present large deletions (46.1%) or large duplications (19.7%) in the dystrophin gene. The remaining 34.2% correspond to point mutations, and half of these correspond to nonsense mutations. In this study we identified 23 new mutations in DMD: 7 large deletions and 16 point mutations.
Conclusions:
The algorithm for genetic diagnosis applied by the participating centres is the most appropriate for genotyping patients with DMD. The genetic specificity of different therapies currently being developed emphasises the importance of identifying the mutation appearing in each patient; 38.7% of the cases in this series are eligible to participate in current clinical trials.
Keywords:
Análisis mutacional; Diagnóstico genético; Distrofia muscular Duchenne; Duchenne muscular dystrophy; Genetic diagnosis; Multiplex ligation-dependent probe amplification; Mutational analysis; Secuenciación; Sequencing.
Copyright © 2016 Sociedad Española de Neurología. Publicado por Elsevier España, S.L.U. All rights reserved.
MeSH terms
-
Adult
-
DNA Mutational Analysis
-
Dystrophin / genetics
-
Gene Deletion
-
Genotype
-
Humans
-
Male
-
Muscular Dystrophy, Duchenne / epidemiology
-
Muscular Dystrophy, Duchenne / genetics*
-
Spain / epidemiology